admin's blog

We're back online!

As many of you will be aware, a few months ago Biofind was hit by a sustained and sophisticated spam campaign which took our community offline for several weeks. We've spent a lot of time upgrading our systems to be able to cope with this and introduced several new security features such as reCaptcha. We are pleased to announce that Biofind is now back up and running and stable again.

What are Third Party Controls and Why are they Important?

Guest blog from: Randox

Laboratory Quality control refers to the process of detecting analytical errors within the lab to ensure both the reliability and accuracy of test results in order to provide the best possible patient care. Unreliable performance can result in misdiagnosis, delayed treatment and increased costs due to retesting etc. it is therefore of great importance to ensure all results provided are both accurate and reliable.

Guest Blog: Coronary Artery Disease

Guest Blog from Randox Laboratories

Coronary artery disease (CAD) is the most common type of heart disease. It is the leading cause of death in the United States in both men and women(1), and affects about 14 million in the US(2).

Become a Guest Blogger on Biofind!

Fancy being a guest blogger for Biofind? Review our guest blogger guidelines here.

Threaded Comments

Hello all,

We recently experimented with adding threaded comments to the rumor mill in an attempt to facilitate multiple strands of conversation within a rumor.

Difficulties Over the Weekend

Apologies to all of our users for any inconvenience caused by our malfunctioning spam filter over the weekend. We're back working and looking forward to your comments and rumors!

Apologies again,

The Biofind Team

Biofind comments and feedback

We welcome feedback and comment on the Biofind website. Please post your feedback here so that we can easily respond where appropriate.

Biofind in 2009

A happy new year to all of our community members. Thank you for your continued support throughout 2008 whilst we moved the site to a new platform.

Response to Feedback

Greetings all,
First off, a thank you for your valued feedback. We've received many comments about the new site, both positive and critical, and we've just implemented our first round of changes.
Less Intrusive Advertising
Biofind is supported by advertising; however the site did suffer a bug whereby threads with only a few comments received excessive amount of ads, making following and tracking discussion difficult. We have now fixed this bug, and the number of adverts displayed within a thread of discussion is now correctly linked to the number of comments.
Presentation of Threads
We have also focussed upon simplifying the visual display of threads. Increasing the body content size, removing the repetitive thread titles and making user actions clearer have resulted in a rumors which are far easier to read and follow. This is in addition to changes in presentation across the rest of the site.
Jobs
We have partnered with RealMatch to provide relevant and targeted job vacancies across the Biotech industry. Our jobs channel is now open and free for all users to use.

Welcome to Biofind v3

Welcome to the third iteration of Biofind!

With the new look website we have moved platforms from our own in-house solution. Rebuilding Biofind has allowed us add new features to the website, including a completely revamped and refitted Rumor Mill.

Along with a new look, the new website involves some revised posting requirements.

Firstly, it is still possible to post rumors and comments without a user account.

We understand that in the past malicious posters have ruined genuine discussing, hiding behind a veil of anonymity. Therefore, when posting a new rumor, registered users can opt to disallow anonymous replies.